NSC5844
NSC5844 (RE-640) is a 4-aminoquinoline derivative, with antitumor and antimalarial activity.
Product Specifications
CAS Number
[140926-75-6]
Product Name Alternative
RE-640
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/NSC5844.html
Purity
98.0
Solubility
DMSO : 1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
ClC1=CC=C2C(NCCNC3=CC=NC4=CC(Cl)=CC=C34)=CC=NC2=C1
Molecular Formula
C20H16Cl2N4
Molecular Weight
383.27
Precautions
H302, H315, H319
References & Citations
[1]Zhang H, et al. Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives. Biomed Pharmacother. 2008 Feb;62 (2) :65-9. Epub 2007 May 24.|[2]Vennerstrom JL, et al. Bisquinolines. 1. N, N-bis (7-chloroquinolin-4-yl) alkanediamines with potential against chloroquine-resistant malaria. J Med Chem. 1992 May 29;35 (11) :2129-34.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Plasmodium
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6122130-01 0.1 mL
CD30 (CD30L receptor, Cytokine receptor CD30, Ki-1 antigen, Lymphocyte activation antigen CD30, Tumor necrosis factor receptor Superfamily member 8 (TNFRSF8)) (APC)
Ask
View Details MBS6122130-02 5x 0.1 mL
CD30 (CD30L receptor, Cytokine receptor CD30, Ki-1 antigen, Lymphocyte activation antigen CD30, Tumor necrosis factor receptor Superfamily member 8 (TNFRSF8)) (APC)
Ask
View Details 